首页 | 本学科首页   官方微博 | 高级检索  
     


Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1
Authors:Christian Renaud  Jane Kuypers  Janet A. Englund
Affiliation:aFred Hutchinson Cancer Research Center, 1100 Fairview Ave. North, P.O. Box 19024, D3-100, Seattle, WA 98109-1024, United States;bUniversity of Washington, Molecular Virology Laboratory, 1616 Eastlake Ave East, Suite 320, Seattle, WA 98102-1024, United States;cPediatric Infectious Diseases, Seattle Childrens’ Hospital, 4800 Sand Point Way #R5441, Seattle, WA 98105, United States
Abstract:The emergence of oseltamivir resistance in seasonal and pandemic influenza A/H1N1 has created challenges for diagnosis and clinical management. This review discusses how clinical virology laboratories have handled diagnosis of oseltamivir-resistant H1N1 and what we have learned from clinical studies and case series. Immunocompetent patients infected with oseltamivir-resistant H1N1 have similar outcomes as patients infected with oseltamivir-susceptible H1N1. However, immunocompromised patients infected with oseltamivir-resistant H1N1 experience potentially more risks of complication and transmissibility with few therapeutic options.
Keywords:Abbreviations: HA, hemagglutinin   NA, neuraminidase   SNP, single nucleotide polymorphism   IC50, 50% inhibitory concentration   NI, neuraminidase inhibition   IV, intra-venous
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号